UBE2Q2
Ubiquitin-conjugating enzyme E2 Q2
Also known as: DKFZp762C143, UB2Q2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8WVN8
- Gene
- UBE2Q2
- Ensembl
- ENSG00000140367
- Chromosome
- 15
- Canonical length
- 375 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
OverviewNCBI Gene
Enables ubiquitin-protein transferase activity. Involved in protein K48-linked ubiquitination. Predicted to be located in cytosol. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
375 residues, UniProt reviewed canonical sequence.
>Q8WVN8|UBE2Q2
1 MSVSGLKAEL KFLASIFDKN HERFRIVSWK LDELHCQFLV PQQGSPHSLP PPLTLHCNIT
61 ESYPSSSPIW FVDSEDPNLT SVLERLEDTK NNNLLRQQLK WLICELCSLY NLPKHLDVEM
121 LDQPLPTGQN GTTEEVTSEE EEEEEEMAED IEDLDHYEMK EEEPISGKKS EDEGIEKENL
181 AILEKIRKTQ RQDHLNGAVS GSVQASDRLM KELRDIYRSQ SYKTGIYSVE LINDSLYDWH
241 VKLQKVDPDS PLHSDLQILK EKEGIEYILL NFSFKDNFPF DPPFVRVVLP VLSGGYVLGG
301 GALCMELLTK QGWSSAYSIE SVIMQINATL VKGKARVQFG ANKNQYNLAR AQQSYNSIVQ
361 IHEKNGWYTP PKEDGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against UBE2Q2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 38 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 38 nTPM
- retina: 36 nTPM
- colon: 35 nTPM
- spinal cord: 30 nTPM
- thyroid gland: 30 nTPM
- blood vessel: 29 nTPM
Single-cell type
- cone photoreceptor cells: 356 nCPM
- rod photoreceptor cells: 243 nCPM
- extravillous trophoblasts: 229 nCPM
- syncytiotrophoblasts: 165 nCPM
- ocular epithelial cells: 155 nCPM
- gonadotrophs: 128 nCPM
Immune cell
- basophil: 31 nTPM
- eosinophil: 21 nTPM
- NK-cell: 15 nTPM
- memory CD4 T-cell: 12 nTPM
- MAIT T-cell: 11 nTPM
- non-classical monocyte: 10 nTPM
Brain region
- white matter: 32 nTPM
- spinal cord: 30 nTPM
- midbrain: 30 nTPM
- pons: 29 nTPM
- hypothalamus: 28 nTPM
- medulla oblongata: 27 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.94
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.62
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads UBE2Q2 as an antibody target. Whether an autoantibody or antibody against UBE2Q2 could matter depends on whether native UBE2Q2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
UBE2Q2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label UBE2Q2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...